Reducing Asthma Disparities by Improving Provider-Patient Communication

Asthma Clinical Trial

Official title:

Reducing Asthma Disparities by Improving Provider-Patient Communication About Asthma Severity and Adherence With Therapy

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00181194
• Other study ID #: 20021855
• Status: Completed
• Start date: May 2005
• Est. completion date: December 2012

Study information

• Verified date: August 2018
• Source: Johns Hopkins University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study will be to assess the impact of a culturally-sensitive, patient-focused asthma communication instrument (ACCI) designed to enhance provider-patient communication by prompting and guiding providers in assessments of disease severity and discussion of adherence behaviors with minority patients with asthma.

Description:

Improving communication between health care providers and their patients is the critical first step in efforts designed to reduce asthma-related health disparities in urban areas. Improving communication will help providers tailor asthma therapies to their patients' needs, and help providers and patients to overcome barriers (e.g., concerns about adverse effects) to adherence with those asthma treatment plans.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 350
• Est. completion date: December 2012
• Est. primary completion date: December 2006
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years to 85 Years

Eligibility

Inclusion Criteria:

• are able to provide informed consent;

• report physician-diagnosed asthma;

• report asthma symptoms and/or use of short-acting reliever medication at least twice weekly in the past month.

Exclusion Criteria:

• state they do not have asthma;

• have mild intermittent disease

• no recent evidence of disease activity.

Related Conditions & MeSH terms

• Asthma

Intervention

Device:
• Asthma Control and Communication Instrument

Locations

Country	Name	City	State
United States	Johns Hopkins Asthma And Allergy Center	Baltimore	Maryland

Sponsors (2)

Lead Sponsor	Collaborator
Johns Hopkins University	National Institutes of Health (NIH)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Accuracy of Provider Assessment of Asthma Severity
Primary	Accuracy of Clinician Assessment of Patient Adherence
Primary	Assessment of appropriateness of asthma treatment (consistency of care with asthma guidelines
Primary	Patient satisfaction with provider-patient communication and medical care
Secondary	These outcomes include indicators of poor asthma control such as health care service use for asthma exacerbations (unscheduled office visits, ER visits, hospitalizations) and use of oral corticosteroid and overuse of inhaled beta-agonist medications.